search
Back to results

The ROB-OSTIAL Study

Primary Purpose

Coronary Artery Disease

Status
Terminated
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Robotic-assisted PCI with Corpath GRX® System
Standard PCI
Sponsored by
Corindus Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease focused on measuring Ostial Lesion, Robotic-assisted PCI, PCI

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Male or nonpregnant female aged ≥18 years Coronary OSTIAL lesion suitable for percutaneous coronary intervention (PCI) The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: Cardiogenic shock or hemodynamic instability requiring support. ST-elevation myocardial infarction. Ongoing acute renal failure. In the opinion of the investigator, the subject is deemed unsuitable for robotic PCI due to clinical status and/or anatomic characteristics More than one lesion to be treated Ostial left main disease

Sites / Locations

  • Maria Cecilia Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Robotic-assisted PCI with Corpath GRX® System

Standard PCI

Arm Description

Percutaneous coronary intervention (PCI) using the Corpath GRX System.

Percutaneous coronary intervention (PCI) using manual techniques. This arm will be completed without robotic assistance.

Outcomes

Primary Outcome Measures

Evidence of full ostial coverage at angiographic and IVUS assessment
Procedure-dependent geographic miss in millimeters (mm) obtained using intravascular ultrasound (IVUS)

Secondary Outcome Measures

Distance from most proximal stent strut and coronary ostium (mm), as assessed by IVUS

Full Information

First Posted
November 17, 2022
Last Updated
September 18, 2023
Sponsor
Corindus Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05634538
Brief Title
The ROB-OSTIAL Study
Official Title
Robotically Assisted PCI in Ostial Lesions
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Terminated
Why Stopped
Sponsor strategic decision
Study Start Date
March 30, 2023 (Actual)
Primary Completion Date
May 8, 2023 (Actual)
Study Completion Date
May 8, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Corindus Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the accuracy of robotic-assisted percutaneous coronary intervention (PCI) using the CorPath GRX® System, versus standard PCI when treating ostial lesions. CorPath GRX System (the Device) is a robotic-like device that is cleared for the remote delivery and control of heart catheterization devices. It helps doctors insert and move heart catheters (a thin, flexible tube) and similar types of devices inside patients blood vessels to treat the blockage in their heart. The results will help to evaluate whether procedures using the CorPath GRX result in more accurate stenting (placing of a tube to keep heart vessel open) compared to standard PCI.
Detailed Description
To assess accuracy of robotic-assisted PCI in obtaining full ostial lesion coverage and minimal protrusion compared to standard PCI. Robotically assisted PCI offers the opportunity of performing minimal device movements (up to a minimum of 1 mm) in a stable and reproducible setting. This feature may be of great help when dealing with ostial lesions, whose treatment requires a precise stent positioning to avoid strut protrusion but also geographic miss of the lesion. Robotic-assisted PCI for ostial lesions showed encouraging results in large observational registries, but no study compared this approach with standard PCI. The aim is to perform a randomized (1:1) study comparing standard (n=33) and robotic-assisted PCI (n=33) in obtaining full lesion coverage when treating ostial lesions (ostial left main will be excluded). Primary endpoint of the study will be full ostial coverage as assessed by IVUS imaging, while secondary endpoints will be procedural success, vessel damage and number of protruding struts in the donor vessel as assessed by IVUS imaging.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
Ostial Lesion, Robotic-assisted PCI, PCI

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Robotic-assisted PCI with Corpath GRX® System
Arm Type
Active Comparator
Arm Description
Percutaneous coronary intervention (PCI) using the Corpath GRX System.
Arm Title
Standard PCI
Arm Type
Active Comparator
Arm Description
Percutaneous coronary intervention (PCI) using manual techniques. This arm will be completed without robotic assistance.
Intervention Type
Device
Intervention Name(s)
Robotic-assisted PCI with Corpath GRX® System
Intervention Description
The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary interventions (PCI).
Intervention Type
Procedure
Intervention Name(s)
Standard PCI
Intervention Description
Percutaneous coronary intervention (PCI) is a procedure used to treat the blockages in a coronary artery; it opens up narrowed or blocked sections of the artery, restoring blood flow to the heart. This arm will be completed without robotic assistance.
Primary Outcome Measure Information:
Title
Evidence of full ostial coverage at angiographic and IVUS assessment
Description
Procedure-dependent geographic miss in millimeters (mm) obtained using intravascular ultrasound (IVUS)
Time Frame
Measured at end of procedure
Secondary Outcome Measure Information:
Title
Distance from most proximal stent strut and coronary ostium (mm), as assessed by IVUS
Time Frame
Measured at end of procedure
Other Pre-specified Outcome Measures:
Title
Comparison of participants with in-hospital major cardiovascular events
Time Frame
Measured at discharge or 72 hours, whichever comes first
Title
Procedural duration
Description
Defined as the duration from when the sheath is inserted until it is removed
Time Frame
Measured at end of procedure
Title
Major adverse cardiovascular events at 1 month follow-up
Time Frame
Measured at 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or nonpregnant female aged ≥18 years Coronary OSTIAL lesion suitable for percutaneous coronary intervention (PCI) The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: Cardiogenic shock or hemodynamic instability requiring support. ST-elevation myocardial infarction. Ongoing acute renal failure. In the opinion of the investigator, the subject is deemed unsuitable for robotic PCI due to clinical status and/or anatomic characteristics More than one lesion to be treated Ostial left main disease
Facility Information:
Facility Name
Maria Cecilia Hospital
City
Cotignola
State/Province
RA
ZIP/Postal Code
48033
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

The ROB-OSTIAL Study

We'll reach out to this number within 24 hrs